Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

US Patent 9255273 · Granted Feb 9, 2016

Estimated economic value: $32,809,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Boron-containing rho kinase inhibitors2025
Axle structure with asymmetrically arranged brake cylinders2024
Dihydropyrrolopyridine inhibitors of ROR-gamma2022
Modulators of ROR-gamma2021
Dihydropyrrolopyridine inhibitors of ROR-gamma2021
Boron-containing diacylhydrazines2020
Substituted benzoimidazoles as modulators of ROR-γ2020
Benzimidazole derivatives as modulators of ROR-gamma2020
Dihydropyrrolopyridine inhibitors of ROR-gamma2020
Chiral diacylhydrazine ligands for modulating the expression of exogenous genes 2020
Boron-containing diacylhydrazine compounds2020
Crystalline diacylhydrazine and the use thereof2019